Ultherapy PRIME, a groundbreaking ultrasound technology, significantly advances noninvasive skin treatments. With real-time imaging, it delivers personalized and long-lasting lifts, targeting precise tissue layers where collagen and elastin reside.
Ultherapy PRIME builds upon the legacy of Ultherapy, recognized as the gold standard for skin tightening and lifting. Clinical studies and over 56 clinical trials have established its safety and efficacy, ensuring patient satisfaction with natural-looking results lasting up to a year or more.
Ultherapy PRIME’s advanced technology allows for customized treatments tailored to each patient’s unique skin needs. It targets the appropriate tissue layers, delivering precise energy to maximize results. Whether it’s for lifting the brows, smoothing lines and wrinkles on the neck, or enhancing chest skin, Ultherapy PRIME offers a solution for all skin types and tones.
The upgraded platform features a modern design with faster processing and elevated ergonomics, enhancing the workflow for healthcare professionals. A larger screen and brighter images provide unparalleled visualization, allowing precise targeting and consistent results.
Merz Aesthetics, the leader in noninvasive lifting, continues to innovate with Ultherapy PRIME. Its commitment to research and development has resulted in a premier platform that provides a truly personalized and long-lasting solution for patients seeking a youthful and rejuvenated appearance.
Jon Napitupulu is Director of Media Relations at The Clinical Trial Vanguard. Jon, a computer data scientist, focuses on the latest clinical trial industry news and trends.
